-
Aug 11, 10 11:25PMThe investigators hypothesize that the response signature would enable us to stratify patients according to predicted drug response to standard-of-care therapy and hence increase treatment response in an enriched patient group.Location: National University Hospital Status: Not yet recruiting» Read more
-
Aug 12, 10 01:50AMResearchers hope to determine if the DNA is shortened in your body and determine if there is an increase in the protein that shortens DNA called telomerase.Location: University of Kansas Medical Center, Westwood C... Status: Not yet recruiting» Read more
-
Aug 12, 10 02:31AMThe primary aim of this study is to determine if mutations of BRCA1 and BRCA2 result in different precancerous pathways to pancreatic ductal adenocarcinoma (PDAC), as suggested in our validated mouse model. Genomic DNA will be isolated on normal tissue obtained from patients who underwent pancreatic resection for PDAC, intraductal papillary mucinous neoplasm (IPMN) or mu...Location: Columbia University Medical Center Status: Recruiting» Read more
-
Aug 12, 10 03:56AMThe purpose of this study is: 1. To characterize the types and frequency of molecular alterations to the epidermal growth factor receptor (EGFR) pathway, FGFR4 and EML-ALK in Asian patients with non-small cell lung cancer 2. To identify candidate biomarkers of importance in the EGFR and estrogen pathways Most, if not all, human malignancies includi...Location: National University Hospital Status: Recruiting» Read more
-
Aug 12, 10 08:28AMPatients with metastatic or locally recurrent triple negative breast cancer (TNBC) who are scheduled for medically indicated surgical biopsy or resection of disease will be identified. Fresh/frozen tissue will be collected and will undergo comprehensive molecular evaluation with NextGen sequencing. TGEN's clonal genomics analyses will be applied in the analysis to identi...Location: Rocky Mountain Cancer Centers Status: Not yet recruiting» Read more
-
Aug 23, 10 09:27AMThis randomized trial is comparing a standard neoadjuvant chemotherapy with a genomic driven chemotherapy in patients with breast cancer.Location: Institut Gustave Roussy Status: Recruiting» Read more
-
Oct 21, 10 08:00AMThe purpose of this study is to evaluate the safety and clinical efficacy of novel peptide vaccination for advanced prostate cancerLocation: Iwate Medical University School of Medicine Status: Recruiting» Read more
-
Nov 02, 10 07:00AMThis is a tumor and serum collection study for patients with advanced breast cancer receiving treatment with lonafarnib.Location: Indiana University Melvin and Bren Simon Cancer... Status: Terminated» Read more
-
Nov 23, 10 05:00AMTPF-C-HIT investigates the combination of induction chemotherapy with TPF followed by radioimmunotherapy with cetuximab and IMRT plus carbon ion boost with regard to efficacy and toxicity of the combination regimen.Location: Dept of Radiation Oncology, University of Heide... Status: Recruiting» Read more
-
Apr 26, 12 07:00AMThyroid cancer is a relatively rare disease but its incidence is increasing in many countries.. Early and accurate diagnosis leading to earlier treatment and intervention is recognised as a major factor in determining a good outcomes. This study will investigate new ways of diagnosing thyroid cancer from blood samples using proteomic and genetic markers. The study will ...Location: Sir Bobby Robson Cancer Researhc Unit Status: Recruiting» Read more